Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
View all What we do
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

Suspected neurological conditions: recognition and referral

NICE guideline
Reference number: NG127
Published: 01 May 2019
Last updated: 02 October 2023

History

Consultation comments published

Consultation comments and responses (PDF 2.48 MB)

Published:

01 May 2019

Equality and health inequalities assessment

Equality impact assessment (PDF 192 KB)

Published:

01 May 2019

Stakeholder list updated

Stakeholder list (PDF 47 KB)

Published:

25 March 2019

Committee meetings

Committee meeting
Minutes 1 (PDF 197 KB)

Published:

08 March 2016
Minutes 2 (PDF 194 KB)

Published:

20 April 2016
Minutes 3 (PDF 194 KB)

Published:

24 May 2016
Minutes 4 (PDF 194 KB)

Published:

13 July 2016
Minutes 5 (PDF 196 KB)

Published:

12 September 2016
Minutes 6 (PDF 193 KB)

Published:

13 September 2016
Minutes 7 (PDF 107 KB)

Published:

02 November 2016
Minutes 8 (PDF 185 KB)

Published:

12 December 2016
Minutes 9 (PDF 184 KB)

Published:

13 December 2016
Minutes 10 (PDF 239 KB)

Published:

01 March 2017
Minutes 11 (PDF 94 KB)

Published:

27 March 2017
Minutes 12 (PDF 95 KB)

Published:

28 March 2017
Minutes 13 (PDF 91 KB)

Published:

10 May 2017
Minutes 14 (PDF 93 KB)

Published:

10 October 2017

Draft guidance consultation

Draft guidance consultation
Draft guideline (PDF 2.11 MB)

Published:

07 August 2017
Short version of draft guideline (PDF 596 KB)

Published:

07 August 2017
Guideline appendices A-R (PDF 2.7 MB)

Published:

07 August 2017
Guideline appendix S (PDF 708 KB)

Published:

07 August 2017
Equality impact assessment 3 (PDF 222 KB)

Published:

07 August 2017
Comments form (MSWord 63 KB)

Published:

07 August 2017
Stakeholder list (PDF 53 KB)

Published:

07 August 2017

Pre-consultation documents released

Economic plan (PDF 112 KB)

Published:

21 June 2017
Review questions (PDF 378 KB)

Published:

21 June 2017
Search strategies (PDF 1.8 MB)

Published:

21 June 2017

Committee list updated

Committee member list (PDF 70 KB)

Published:

16 March 2016

Equality and health inequalities assessment

Equality impact assessment 1 (PDF 260 KB)

Published:

23 August 2016
Equality impact assessment 2 (PDF 291 KB)

Published:

23 August 2016
Equality impact assessment 4 (PDF 217 KB)

Published:

20 June 2018

Scope published

Final scope (PDF 185 KB)

Published:

02 March 2016

Consultation comments published

Consultation comments and responses (PDF 1.41 MB)

Published:

02 March 2016

Draft scope consultation

Draft scope consultation
Draft scope (PDF 190 KB)

Published:

04 December 2015
Equality impact assessment (PDF 258 KB)

Published:

04 December 2015
Comments form (MSWord 41 KB)

Published:

07 December 2015

Scoping workshop

Workshop notes (PDF 331 KB)

Published:

08 December 2015